Please assess the completion status of the following clinical trial:

Trial Title: Use of Intravitreal Bevacizumab in Eyes With Choroidal Neovascularization Secondary to Angioid Streaks

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Angioid Streaks~* Choroidal neovascularization associated~* Untreated patients or patients treated once with PDT~Exclusion Criteria:~* Ocular surgery excepting uncomplicated phacoemulsification~* Glaucoma or any other ocular pathology

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).